IL140420A0 - Methods and transdermal compositions for pain relief - Google Patents
Methods and transdermal compositions for pain reliefInfo
- Publication number
- IL140420A0 IL140420A0 IL14042099A IL14042099A IL140420A0 IL 140420 A0 IL140420 A0 IL 140420A0 IL 14042099 A IL14042099 A IL 14042099A IL 14042099 A IL14042099 A IL 14042099A IL 140420 A0 IL140420 A0 IL 140420A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- pain relief
- transdermal compositions
- transdermal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/106,684 US6290986B1 (en) | 1996-10-24 | 1998-06-29 | Method and composition for transdermal administration of pharmacologic agents |
US12290399P | 1999-03-05 | 1999-03-05 | |
PCT/US1999/014653 WO2000000120A1 (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Publications (1)
Publication Number | Publication Date |
---|---|
IL140420A0 true IL140420A0 (en) | 2002-02-10 |
Family
ID=26803907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14042099A IL140420A0 (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1093348A4 (no) |
JP (1) | JP2002519310A (no) |
KR (1) | KR20010078754A (no) |
CN (1) | CN1331576A (no) |
AU (1) | AU4841599A (no) |
BG (1) | BG105175A (no) |
BR (1) | BR9912508A (no) |
CA (1) | CA2335837A1 (no) |
HR (1) | HRP20000905A2 (no) |
HU (1) | HUP0102728A3 (no) |
ID (1) | ID28213A (no) |
IL (1) | IL140420A0 (no) |
MX (1) | MXPA00012767A (no) |
NO (1) | NO20006604L (no) |
PL (1) | PL345216A1 (no) |
SK (1) | SK20012000A3 (no) |
TR (1) | TR200003801T2 (no) |
WO (1) | WO2000000120A1 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
EP0986540B1 (en) | 1997-04-22 | 2005-02-16 | Euro-Celtique S.A. | The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
PL196996B1 (pl) | 1999-07-01 | 2008-02-29 | Upjohn Co | Zastosowanie optycznie czystej (S,S)-reboksetyny lub jej dopuszczalnej farmaceutycznie soli do wytwarzania leku |
DK1500395T3 (da) * | 1999-07-01 | 2006-06-19 | Pharmacia & Upjohn Co Llc | Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser |
WO2001041732A1 (en) * | 1999-12-06 | 2001-06-14 | Gore Stanley L | Compositions and methods for intranasal delivery of active agents to the brain |
IN191512B (no) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
DE10042412B4 (de) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
SI2218448T1 (sl) | 2002-12-13 | 2016-01-29 | Durect Corporation | Sistem za oralno dajanje zdravila, ki obsega tekoči nosilec materialov z visoko viskoznostjo |
JP2005154368A (ja) * | 2003-11-27 | 2005-06-16 | Teikoku Seiyaku Co Ltd | ジソピラミド含有神経因性疼痛の鎮痛剤 |
JP4807721B2 (ja) * | 2004-01-29 | 2011-11-02 | 株式会社 メドレックス | 消炎鎮痛外用剤 |
ES2378671T3 (es) | 2004-09-17 | 2012-04-16 | Durect Corporation | Composición anestésica local prolongada que contiene SAIB |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
JP2007308403A (ja) * | 2006-05-17 | 2007-11-29 | Kenji Yoshida | 皮膚外用剤 |
KR100880748B1 (ko) * | 2006-08-29 | 2009-02-02 | 정헌택 | 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물 |
EP2117521B1 (en) | 2006-11-03 | 2012-06-27 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
CA2706931C (en) | 2007-12-06 | 2015-05-12 | Durect Corporation | Oral pharmaceutical dosage forms |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
JP5826742B2 (ja) * | 2009-05-07 | 2015-12-02 | ドンコック ファーマシューティカル カンパニー リミテッド | 神経損傷及び神経疾患の予防または治療用薬学組成物 |
US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
AU2014233453A1 (en) | 2013-03-15 | 2015-10-01 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
RU2016136430A (ru) * | 2014-02-11 | 2018-03-15 | Др. Редди'С Лабораторис Лтд. | Парентеральные композиции целекоксиба |
EP3870150A1 (en) | 2018-10-26 | 2021-09-01 | Viramal Limited | Mucoadhesive gel composition |
ES2948955T3 (es) | 2018-11-30 | 2023-09-22 | Viramal Ltd | Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante |
CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4395420A (en) * | 1981-12-09 | 1983-07-26 | Bernstein Joel E | Method and composition for treating pruritis |
SI9300468A (en) * | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
US5885597A (en) * | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
-
1999
- 1999-06-29 WO PCT/US1999/014653 patent/WO2000000120A1/en not_active Application Discontinuation
- 1999-06-29 MX MXPA00012767A patent/MXPA00012767A/es unknown
- 1999-06-29 PL PL99345216A patent/PL345216A1/xx unknown
- 1999-06-29 BR BR9912508-0A patent/BR9912508A/pt not_active Application Discontinuation
- 1999-06-29 CA CA002335837A patent/CA2335837A1/en not_active Abandoned
- 1999-06-29 SK SK2001-2000A patent/SK20012000A3/sk unknown
- 1999-06-29 IL IL14042099A patent/IL140420A0/xx unknown
- 1999-06-29 TR TR2000/03801T patent/TR200003801T2/xx unknown
- 1999-06-29 ID IDW20010231A patent/ID28213A/id unknown
- 1999-06-29 AU AU48415/99A patent/AU4841599A/en not_active Abandoned
- 1999-06-29 EP EP99932017A patent/EP1093348A4/en not_active Withdrawn
- 1999-06-29 HU HU0102728A patent/HUP0102728A3/hu unknown
- 1999-06-29 CN CN99810055A patent/CN1331576A/zh active Pending
- 1999-06-29 JP JP2000556706A patent/JP2002519310A/ja active Pending
- 1999-06-29 KR KR1020007014985A patent/KR20010078754A/ko not_active Application Discontinuation
-
2000
- 2000-12-22 NO NO20006604A patent/NO20006604L/no not_active Application Discontinuation
- 2000-12-28 HR HR20000905A patent/HRP20000905A2/hr not_active Application Discontinuation
-
2001
- 2001-01-24 BG BG105175A patent/BG105175A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
SK20012000A3 (sk) | 2001-08-06 |
CN1331576A (zh) | 2002-01-16 |
KR20010078754A (ko) | 2001-08-21 |
HUP0102728A2 (hu) | 2002-03-28 |
WO2000000120A1 (en) | 2000-01-06 |
CA2335837A1 (en) | 2000-01-06 |
PL345216A1 (en) | 2001-12-03 |
AU4841599A (en) | 2000-01-17 |
EP1093348A1 (en) | 2001-04-25 |
BR9912508A (pt) | 2001-05-02 |
NO20006604D0 (no) | 2000-12-22 |
HUP0102728A3 (en) | 2002-12-28 |
WO2000000120A9 (en) | 2000-03-30 |
EP1093348A4 (en) | 2003-07-16 |
MXPA00012767A (es) | 2002-08-09 |
TR200003801T2 (tr) | 2001-06-21 |
HRP20000905A2 (en) | 2001-08-31 |
NO20006604L (no) | 2001-02-28 |
BG105175A (bg) | 2001-11-30 |
ID28213A (id) | 2001-05-10 |
JP2002519310A (ja) | 2002-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL345216A1 (en) | Methods and transdermal compositions for pain relief | |
AU2002234192A8 (en) | Methods and transdermal compositions for pain relief | |
AU2024500A (en) | Intraoral electromuscular stimulation device and method | |
AU6872498A (en) | Method and composition for skin treatment | |
HUP0103621A3 (en) | Fentanyl composition for the treatment of acute pain | |
EP1065978A4 (en) | IMPLANTABLE THERAPEUTIC DEVICE AND METHOD THEREOF | |
AU5439996A (en) | Compositions and methods for treating pain | |
PL329211A1 (en) | Pain relieving method | |
HK1031174A1 (en) | Compositions and methods for treating diabetes | |
AU7696098A (en) | Substance p inhibitors in combination with nmda-blockers for treating pain | |
AU3877900A (en) | Compositions and methods for preventing and treating sexual dysfunctions | |
AU2542097A (en) | Oligonucleotide treatments and compositions for human melanoma | |
IL116895A (en) | Transdermal patch comprising xanomeline | |
AU3784999A (en) | Methods for treatment of pain | |
AU6056500A (en) | Process and composition for temporarily suppressing pain | |
IL124650A0 (en) | Methods and therapeutic compositions for treating cancer | |
AU3204899A (en) | Hair treatment composition and method | |
EP1007041A4 (en) | COMPOSITION FOR TREATING PAIN | |
AU2420101A (en) | Method and composition for the treatment of pain | |
AU5169200A (en) | Methods and compositions for treating breakthrough pain | |
AU7247898A (en) | Composition for treating pain | |
IL150202A0 (en) | Method and composition for the treatment of pain | |
EP1112250A4 (en) | THERAPEUTIC COMPOUNDS AND RELATED METHODS | |
AU5097099A (en) | Methods and compositions for cancer treatment | |
AU5768300A (en) | Pain relief composition and method of relieving pain |